Wasabi secures more cash for data center expansion after cloud storage launch entices trial users on claims of significantly lower prices, higher performance than Amazon S3. Read more >>
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that recently analyzed skin biopsy histology data from its Phase 2 study of anabasum for the treatment of diffuse cutaneous systemic sclerosis will be presented at the 15th International Workshop on Scleroderma Research. Read more >>
A legally blind man who had not been able to see a soccer match in almost 30 years recently watched his favorite club live with the help of eSight’s visual aid technology. Read more >>
For the first time in 25 years of teaching at Cardinal O’Hara, Ed Allen can see what the hall ways really look like.
“It’s awesome just being able to see this building,” Allen said.
His awesome new world is thanks to the funny looking glasses called eSight. Read more >>
Brian Casey, 51, wears a groundbreaking visual aid technology called eSight
He went to watch Fleetwood Town for the first time only to see them thrashed 5-1
Mr Casey is the first legally blind person in Europe to wear the high tech glasses
They work by showing a live video feed directly in front of the user’s eyes
Read more >>
Babson College is one of the nation’s best institutions for undergraduate education, according to The Princeton Review
Princeton ReviewBabson College, ranked No. 1 for entrepreneurship, is featured in the new 2018 edition of Princeton Review’s college guide, “The Best 382 Colleges.” Read more >>
If you walk into Carbonite CEO Mohamad Ali’s office, you might notice a large white board diagram. Take a closer look, and quite a few of the boxes within the diagram are checked off. A new business plan, perhaps? Read more >>
Myomo, Inc. (NYSE MKT:MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis across the European Economic Area (EEA). The CE Mark indicates MyoPro complies with the essential requirements of relevant EU legislation and has achieved quality system certification. MyoPro is the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of […]
